The kinetics of circulating cytokines including IL-6, TNF-α, IL-8 and IL-10 following allogeneic hematopoietic stem cell transplantation

被引:79
作者
Min, CK
Lee, WY
Min, DJ
Lee, DG
Kim, YJ
Park, YH
Kim, HJ
Lee, S
Kim, DW
Lee, JW
Min, WS
Kim, CC
机构
[1] Catholic Univ Korea, Coll Med, Catholic Hemopoiet Stem Cell Transplantat Ctr, Seoul, South Korea
[2] Catholic Univ Korea, Coll Med, Dept Endocrinol, Seoul, South Korea
[3] Catholic Univ Korea, Coll Med, Dept Rheumatol, Seoul, South Korea
[4] Catholic Univ Korea, Coll Med, Dept Infect Dis, Seoul, South Korea
关键词
allogeneic HSCT; cytokines; complications;
D O I
10.1038/sj.bmt.1703258
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
Pro-inflammatory (IL-6, TNF alpha and IL-8) and antiinflammatory (IL-10) cytokines were determined in weekly samples from 52 patients undergoing allogeneic hematopoietic stem cell transplantation (HSCT). IL-6 increased immediately after transplant peaking at week +3, but IL-8 concentrations were elevated only during week +1. After a slight decrease in week +1, TNF-alpha significantly increased from week +2 and peaked at week +3, whereas, IL-10 values started to rise in week +2 and peaked during week +4. IL-6 and TNF-alpha were positively correlated from week +2 to week +4, and IL-6 levels at week +1 were related with fever and severe stomatitis. Serum levels of IL-6 at week +1 and IL-10 at week +4 were significantly higher in patients with early transplant-related complications, such as fever, severe stomatitis or acute GVHD greater than or equal to overall grade II than in those without the complications. We conclude that a high serum IL-6 level at week +1 may be an early predictor of transplant-related complications and that it seems to trigger pro- and anti-inflammatory cytokine release. Kinetic patterns of IL-6 and IL-10 were more exaggerated in those with complications after HSCT.
引用
收藏
页码:935 / 940
页数:6
相关论文
共 22 条
[1]  
ANTIN JH, 1992, BLOOD, V80, P2964
[2]   High spontaneous IL-10 production in unrelated bone marrow transplant recipients is associated with fewer transplant-related complications and early deaths [J].
Baker, KS ;
Roncarolo, MG ;
Peters, C ;
Bigler, M ;
DeFor, T ;
Blazar, BR .
BONE MARROW TRANSPLANTATION, 1999, 23 (11) :1123-1129
[3]   INTERLEUKIN-6 IS THE MAJOR REGULATOR OF ACUTE PHASE PROTEIN-SYNTHESIS IN ADULT HUMAN HEPATOCYTES [J].
CASTELL, JV ;
GOMEZLECHON, MJ ;
DAVID, M ;
ANDUS, T ;
GEIGER, T ;
TRULLENQUE, R ;
FABRA, R ;
HEINRICH, PC .
FEBS LETTERS, 1989, 242 (02) :237-239
[4]  
CASTENSKIOLD EC, 1995, BONE MARROW TRANSPL, V15, P879
[5]  
CHASTY RC, 1993, BONE MARROW TRANSPL, V12, P331
[6]  
Ferrà C, 1998, HAEMATOLOGICA, V83, P1082
[7]   CLINICAL MANIFESTATIONS OF GRAFT VERSUS HOST DISEASE IN HUMAN RECIPIENTS OF MARROW FROM HL-A-MATCHED SIBLING DONORS [J].
GLUCKSBERG, H ;
STORB, R ;
FEFER, A ;
BUCKNER, CD ;
NEIMAN, PE ;
CLIFT, RA ;
LERNER, KG ;
THOMAS, ED .
TRANSPLANTATION, 1974, 18 (04) :295-304
[8]   High interleukin-10 serum levels are associated with fatal outcome in patients after bone marrow transplantation [J].
Hempel, L ;
Korholz, D ;
Nussbaum, P ;
Bonig, H ;
Burdach, S ;
Zintl, F .
BONE MARROW TRANSPLANTATION, 1997, 20 (05) :365-368
[9]   Prognostic significance of increased IL-10 production in patients prior to allogeneic bone marrow transplantation [J].
Holler, E ;
Roncarolo, MG ;
Hintermeier-Knabe, R ;
Eissner, G ;
Ertl, B ;
Schulz, U ;
Knabe, H ;
Kolb, HJ ;
Andreesen, R ;
Wilmanns, W .
BONE MARROW TRANSPLANTATION, 2000, 25 (03) :237-241
[10]  
HOLLER E, 1990, BLOOD, V75, P1011